2nd MERS Case Confirmed in Qatar

Qatar's Ministry of Public Health (MOPH) recently announced the second case of Middle East Respiratory Syndrome (MERS-CoV). On April 3, 2022, the MOPH reported the male patient had a history of travel outside the country and direct contact with camels.

Furthermore, he developed symptoms before he arrived in Qatar.

And none of his local contacts have displayed symptoms that remain under MOPH observation.

The initial MERS-CoV case in 2022 was confirmed in mid-March.

At the end of February 2022, a total of 2,585 laboratory-confirmed cases of MERS, including 890 associated deaths (case-fatality ratio of 34.4%), were reported to the WHO.

Most of these cases were reported from Saudi Arabia (2,184 cases).

MERS is a viral respiratory disease caused by one of the many coronaviruses.

Still, it differs from the SARS-CoV-2 coronavirus in terms of the source of infection, mode of transmission, and disease severity.

While over twenty COVID-19 vaccines are available globally, as of April 5, 2022, no MERS vaccine candidate has been authorized.

Note: This news article edited various content sources and was manually curated for mobile readers.